News

For this "UK at the Half," University of Kentucky Sanders-Brown Center on Aging Director Linda Van Eldik talks about the life-changing — and lifesaving — work that the center does.

On this episode of "Behind the Blue," Sanders-Brown Center on Aging Director Linda Van Eldik joins UK Public Relations and Strategic Communications' Hillary Smith to discuss the larger game plan of finding a cure for Alzheimer’s and dementia.

Attendees will have the opportunity to hear clinicians and researchers from the University of Kentucky share current findings on dementia and aging disorders.

A recently released paper from the Department of Physiology and Sanders-Brown Center on Aging (SBCoA) suggests that genetics can influence response to Alzheimer’s disease pathology.

Sanders-Brown Center on Aging will receive renewed funding for its Alzheimer’s Disease Research Center (ADRC) program from the National Institute on Aging, a division of the National Institutes of Health.

A recently published study from University of Kentucky Sanders-Brown Center on Aging researcher Justin Miller, Ph.D., found 11 rare genetic variants spanning 10 genes, including previously unknown variants in two known Alzheimer's disease risk genes.

The day was established to raise awareness about Alzheimer’s disease and its impact on the African American community, since their risk of developing Alzheimer’s disease is two to three times higher than white Americans.

A published study focused on polyamines, molecules produced by our own cells and found in the foods we eat. Polyamine supplementation could boost mitochondrial function and memory as we age.

UK Neuroscience Professor Greg Gerhardt's new research program will provide answers to questions about the role of neurotransmitters in the progression of Alzheimer’s disease.

Their work shows that direct measures of brain signatures during mental activity are more sensitive and accurate predictors of memory decline than current standard behavioral testing.